Carefusion Corp (CFN) Misses Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- S&P 500, Nasdaq pare declines as AI rout teeters; healthcare, staples gain
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
- Nebius shares sink on CoreWeave's bond yield spike and insider sales
- IonQ prices $2 billion equity offering at $40 per share
- Rocket Lab delays Neutron rocket debut to 2027
- Bloom Energy stock falls as inflation data pressures markets
- Nasdaq ends sharply lower as hot inflation data stirs rate-hike worries
Goldman Sachs Upgrades CareFusion (CFN) to Neutral
May 6, 2014 6:44 AM EDTGoldman Sachs upgraded CareFusion (NYSE: CFN) from Sell to Neutral with a price target of $40.00 (from $37.00) saying they see post Q3 EPS guidance presenting a more realistic set of expectation.
Analyst David Roman said, "While 3Q14 results missed consensus and GSe, the company... More



